Rss Feed


The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer

Condition:   Ovarian CancerIntervention:   Drug: ZL-2306 (niraparib)Sponsor:   Zai Lab (Shanghai) Co., Ltd.Active, not recruiting
Beijing Cancer Hospital Beijing, Beijing, China, 100000 Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510000 Haerbin Medical University Cancer Hospital Harbin, Heilongjiang, China, 150000 Hunan Cancer Hospital Changsha, Hunan, China, 410013 Fudan University Shanghai Cnacer Center Shanghai, Shanghai, China, 200000 The West China Second UniversityHospital of Sichuan University Chengdu, Sichuan, China, 610000

Original Link...

Tags: None
Report Print

Read On: